MO
33
-2
WMB
62
-13
CMS
62
-5
V
36
-38
WEC
39
-28
LNC
26
-3
RF
45
-2
CNX
50
2
AAP
30
6
BAX
23
5
M
40
-3
MU
62
4
NFLX
54
-3
FFIV
49
3
DE
48
2
CSCO
56
2
ZION
45
-26
MKC
36
-6
MPC
67
7
ORCL
38
10
MO
33
-2
WMB
62
-13
CMS
62
-5
V
36
-38
WEC
39
-28
LNC
26
-3
RF
45
-2
CNX
50
2
AAP
30
6
BAX
23
5
M
40
-3
MU
62
4
NFLX
54
-3
FFIV
49
3
DE
48
2
CSCO
56
2
ZION
45
-26
MKC
36
-6
MPC
67
7
ORCL
38
10
Financhill
Back

Insmed, Inc. 10K Form

Sell
32

INSM
Insmed, Inc.

Last Price:
$139.55
Seasonality Move:
4.8%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-09 10Q INSM/Insmed, Inc. Quarterly
2023-10-26 10Q INSM/Insmed, Inc. Quarterly
2023-08-03 10Q INSM/Insmed, Inc. Quarterly
2023-05-04 10Q INSM/Insmed, Inc. Quarterly
2022-10-27 10Q INSM/Insmed, Inc. Quarterly
2022-08-04 10Q INSM/Insmed, Inc. Quarterly

Receive INSM News And Ratings

See the #1 stock for the next 7 days that we like better than INSM

INSM Financial Statistics

Sales & Book Value

Annual Sales: $606.4M
Cash Flow: $-294.2M
Price / Cash Flow: 0
Annual Sales: $3.45
Price / Book: 40.66

Profitability

EPS (TTM): -6.40300
Net Income (TTM): $-1.3B
Gross Margin: $477.5M
Return on Equity: -192.35%
Return on Assets: -58.39%

Insmed, Inc. Earnings Forecast

Key Insmed, Inc. Financial Ratios

  • The Gross Profit Margin over the past 27 years for INSM is 78.74%.
  • The Selling, General & Administrative Expenses for INSM have been equal to 115.62% of Gross Profit Margin.
  • The Research & Development expenses have been 127.15% of Revenue.
  • The Net Earning history of INSM is -210.54% of Total Revenues.
  • Per Share Earnings over the last 27 years have been positive in 9 years.

Insmed, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: INSM
CUSIP: 457669
Website: insmed.com

Debt

Debt-to-Equity Ratio: 1.02
Current Ratio: 3.83
Quick Ratio: 3.35

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 348.47

INSM Technical Analysis vs Fundamental Analysis

Sell
32
Insmed, Inc. (INSM) is a Sell

Is Insmed, Inc. a Buy or a Sell?

  • Insmed, Inc. stock is rated a Sell
    The current Insmed, Inc. [INSM] share price is $139.40. The Score for INSM is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.